Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds.

Bezzio, Cristina; Manes, Gianpiero; Bini, Francesco; Pellegrini, Lucienne; Saibeni, Simone

Bezzio, Cristina; Manes, Gianpiero; Bini, Francesco; Pellegrini, Lucienne; Saibeni, Simone.

Bezzio C; Gastroenterology Unit, ASST Rhodense, Garbagnate Milanese, Italy cribezzio03@yahoo.it.
Manes G; Gastroenterology Unit, ASST Rhodense, Garbagnate Milanese, Italy.
Bini F; Pneumology Unit, ASST Rhodense, Garbagnate Milanese, Italy.
Pellegrini L; Gastroenterology Unit, ASST Rhodense, Garbagnate Milanese, Italy.
Saibeni S; Gastroenterology Unit, ASST Rhodense, Garbagnate Milanese, Italy.

Gut ; 70(3): 623-624, 2021 03.

Article in English | MEDLINE | ID: covidwho-1066904

Subject(s)

COVID-19; Colitis, Ulcerative; Colitis, Ulcerative/drug therapy; Gastrointestinal Agents/therapeutic use; Humans; Immunomodulation; Infliximab/therapeutic use; SARS-CoV-2

Keywords

IBD

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Colitis, Ulcerative / COVID-19 Limits: Humans Language: English Journal: Gut Year: 2021 Document Type: Article Affiliation country: Gutjnl-2020-321760

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google